According to the expression levels of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), and Ki67, breast cancer is classified into Luminal A, Luminal B, HER2 over-expression and Basal-like (Triple negative) sub-types [2]. This evidence concerns the gene MKI67 and breast carcinoma.